FIDIA PHARMA USA INC. is a fully owned subsidiary of Fidia Farmaceutici S.p.A., a global pharmaceutical leader in hyaluronic acid (HA) based products which was founded in 1946 in Abano, Italy.
FIDIA PHARMA USA INC. began operating in 2011 and is headquartered in Parsippany, N.J.
Since its inception, our team of professionals has focused on expanding Fidia’s position in the U.S. and Canadian markets, providing its customers with unique, innovative and reliable HA based treatment options.
Our primary therapeutic areas are knee joint healthcare and women’s health.
FIDIA PHARMA USA INC. is committed to four leading principles. Through our employees and research, we develop and deliver value added solutions to healthcare challenges:
Innovation, to have product lines to treat common pathologies with a major social impact and to offer integrated solutions reflecting the need to reduce health costs without compromising quality and reliability.
Quality, using state-of-the-art systems following the strictest regulations and highest safety standards on the national and international level.
Globalization, withFidia’s products present in over 80 markets worldwide through a comprehensive network of subsidiaries, affiliates and distributors. Our goal is to establish and strengthen Fidia’s presence in the US and globally.
Competitiveness, to enable Fidia to be a market leader using the latest methods based on science and long-standing tradition for research.
Because our passion is your health.